Advances In Therapy SCIE

国际简称：ADV THER 参考译名：治疗进展

主要研究方向：医学-药学非预警期刊审稿周期：较慢,6-12周

《治疗进展》(Advances In Therapy)是一本由Springer Healthcare出版的以医学-药学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q2 JCR分区
345 年发文量
3.4 IF影响因子
未开放 是否OA
53 H-index
2000 创刊年份
Monthly 出版周期
English 出版语言

Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

[ 查看全部 ]

投稿咨询加急咨询

投稿热线：400-888-7501

Advances In Therapy期刊信息

ISSN：0741-238X
出版语言：English
是否OA：未开放
E-ISSN：1865-8652
出版地区：ENGLAND
是否预警：否
出版商：Springer Healthcare
出版周期：Monthly
创刊时间：2000
开源占比：0.6908
Gold OA文章占比：68.88%
OA被引用占比：0.7717...
出版国人文章占比：0.07
出版撤稿占比：0
研究类文章占比：77.10%

Advances In Therapy CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

7.2

1.089

1.316

学科类别	分区	排名	百分位
大类：Medicine 小类：Pharmacology (medical)	Q1	52 / 272	81%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Advances In Therapy中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验 PHARMACOLOGY & PHARMACY 药学	3区 3区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验 PHARMACOLOGY & PHARMACY 药学	3区 3区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学 MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验	3区 4区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验 PHARMACOLOGY & PHARMACY 药学	3区 3区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学 MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验	3区 4区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验 PHARMACOLOGY & PHARMACY 药学	3区 3区

Advances In Therapy JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	76 / 189	60.1%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	105 / 354	70.5%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	71 / 189	62.7%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	130 / 354	63.42%

Advances In Therapy历年数据统计

影响因子

中科院分区

Advances In Therapy中国学者发文选摘

1、The Importance of Integrated Regulation Mechanism of Coronary Microvascular Function for Maintaining the Stability of Coronary Microcirculation: An Easily Overlooked Perspective
Author: Zhu, Houyong; Wang, Hanxin; Zhu, Xinyu; Chen, Qilan; Fang, Xiaojiang; Xu, Xiaoqun; Ping, Yan; Gao, Beibei; Tong, Guoxin; Ding, Yu; Chen, Tielong; Huang, Jinyu

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 1, pp. 76-101. DOI: 10.1007/s12325-022-02343-7
2、Peripheral T-reg Levels and Transforming Growth Factor-beta (TGF beta) in Patients with Psoriatic Arthritis: A Systematic Review Meta-Analysis
Author: Su, Qin-Yi; Zhang, Sheng-Xiao; Yang, Liu; Luo, Jing; Li, Xiao-Feng; Zhang, Jia-Qi; Zhang, Yan; Liu, Jun-Qi; Shi, Lei

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 1, pp. 102-116. DOI: 10.1007/s12325-022-02337-5
3、Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer
Author: Zheng, Jian; Zhang, Yi-Fan; Han, Guo-Hui; Fan, Meng-Ying; Du, Ming-Hui; Zhang, Guo-Chen; Zhang, Bo; Qiao, Jun; Zhang, Sheng-Xiao; Cao, Ji-Min

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 1, pp. 310-330. DOI: 10.1007/s12325-022-02330-y
4、Recurrence Rates and Pharmacological Treatment for Hemorrhoidal Disease: A Systematic Review
Author: Lohsiriwat, Varut; Sheikh, Parvez; Bandolon, Robert; Ren, Dong-Lin; Roslani, April Camilla; Schaible, Kassandra; Freitag, Andreas; Martin, Monique; Yaltirik, Pelin; Godeberge, Philippe

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 1, pp. 117-132. DOI: 10.1007/s12325-022-02351-7
5、Cost-Effectiveness of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease from Chinese Healthcare Perspective
Author: Xie, Wenwen; Song, Yinyin; Qin, Xiaomei; Jin, Pengfei

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 2, pp. 489-503. DOI: 10.1007/s12325-022-02372-2
6、Quick and Accurate Placement of Cannulated Screws to Internal Fixation of Femoral Neck Fractures Using a Novel Guide Device
Author: Ren, Bu-fang; Li, Gang; Ma, Quan-ping; Lv, Xin; Sun, Jian

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 3, pp. 844-852. DOI: 10.1007/s12325-022-02374-0
7、Efficacy and Safety of PD-1/PD-L1 Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
Author: Liu, Yuwei; Pan, Jiahui; Gao, Fangbo; Xu, Wentao; Li, Hongyu; Qi, Xingshun

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 2, pp. 521-549. DOI: 10.1007/s12325-022-02371-3
8、The MODIFY Study Protocol: An Open-Label, Single-Arm, Multicenter, Prospective Pragmatic Study of Ixazomib-Based Triple-Drug Therapy in Chinese Patients with Multiple Myeloma
Author: Chen, Wenming; Liu, Aijun; Li, Lin

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 2, pp. 705-717. DOI: 10.1007/s12325-022-02355-3